GRI Bio, Inc.
GRI
$1.80
-$0.20-10.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.49% | -16.46% | -45.68% | -36.09% | -20.90% |
| Total Depreciation and Amortization | -25.00% | 0.00% | 0.00% | 111.43% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.53% | 194.59% | 2,002.50% | 775.83% | 331.82% |
| Change in Net Operating Assets | -409.23% | -289.26% | 306.47% | 132.39% | 115.02% |
| Cash from Operations | -13.59% | -49.01% | -18.29% | 24.30% | 18.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 90.82% | 167.54% | 12.23% | -13.49% | -10.65% |
| Repurchase of Common Stock | 0.00% | 0.00% | -100.00% | 0.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.02% | -140.33% | -6.69% | -172.77% | -160.89% |
| Cash from Financing | 104.62% | 171.41% | 13.18% | -36.54% | -37.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 573.19% | 1,058.89% | -0.59% | -154.93% | -179.21% |